These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1358192)

  • 1. Monoclonal antibodies in corneal transplantation.
    Williams KA; Coster DJ
    Br J Ophthalmol; 1992 Oct; 76(10):577. PubMed ID: 1358192
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody.
    Ayliffe W; Alam Y; Bell EB; McLeod D; Hutchinson IV
    Br J Ophthalmol; 1992 Oct; 76(10):602-6. PubMed ID: 1358194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rejection of discordant skin xenografts by CD4- CD8- TCR alpha beta+ cells in CD4- and CD8-deficient mice.
    Umesue M; Mayumi H; Kong YY; Omoto K; Muranaka H; Nakanishi R; Kohno H; Yasumoto K; Kishihara K; Nomoto K
    Transplant Proc; 1999; 31(1-2):890-1. PubMed ID: 10083391
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-dose, short-term treatment with anti-CD4 monoclonal antibody prolongs corneal allograft survival.
    Thiel MA; Takano T; Hawksworth N; Coster DJ; Williams KA
    Transplant Proc; 2001; 33(1-2):635-6. PubMed ID: 11266993
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppression of canine renal allograft recipients by CD4 and CD8 monoclonal antibodies.
    Watson CJ; Cobbold SP; Davies HS; Rebello PR; Thiru S; McNair R; Rasmussen A; Waldmann H; Calne RY; Metcalfe SM
    Tissue Antigens; 1994 Mar; 43(3):155-62. PubMed ID: 7916496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Infectious" transplantation tolerance.
    Qin S; Cobbold SP; Pope H; Elliott J; Kioussis D; Davies J; Waldmann H
    Science; 1993 Feb; 259(5097):974-7. PubMed ID: 8094901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 and CD8 monoclonal antibody therapy: strategies to prolong renal allograft survival in the dog.
    Watson CJ; Cobbold SP; Davies HS; Rebello PR; Waldmann H; Calne RY; Metcalfe SM
    Br J Surg; 1993 Nov; 80(11):1389-92. PubMed ID: 8252344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK 506 versus cyclosporine in combination with anti-CD4/CD8 monoclonal antibodies.
    Moffatt SD; Metcalfe SM
    Transplant Proc; 1999 Nov; 31(7):2740. PubMed ID: 10578271
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative efficacy of liposomal FK 506 with FK 506 (tacrolimus) with and without anti-CD4/CD8 monoclonal antibodies.
    Moffatt SD; McAlister V; Calne RY; Metcalfe SM
    Transplant Proc; 1999 Nov; 31(7):2754. PubMed ID: 10578277
    [No Abstract]   [Full Text] [Related]  

  • 10. Indefinite survival of neural xenografts induced with anti-CD4 monoclonal antibodies.
    Wood MJ; Sloan DJ; Wood KJ; Charlton HM
    Neuroscience; 1996 Feb; 70(3):775-89. PubMed ID: 9045088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD4/CyA therapy causes prevention of autoimmune but not allogeneic destruction of grafted islets in BB rats.
    Kuttler B; Rösing K; Hahn HJ
    Transplant Proc; 1997 Jun; 29(4):2163-5. PubMed ID: 9193572
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of monoclonal antibody on corneal graft survival across major and minor histocompatibility mismatches.
    Duguid IG; Koulmanda M; Mandel TE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):844. PubMed ID: 8438499
    [No Abstract]   [Full Text] [Related]  

  • 13. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of IL-4 does not prevent tolerance induction in an allogeneic rat kidney transplantation model.
    Ritter T; Seifert M; Risch K; Fretz A; Tanzmann H; Brock J; Volk HD; Lehmann M
    Transplant Proc; 1999; 31(1-2):887-8. PubMed ID: 10083389
    [No Abstract]   [Full Text] [Related]  

  • 15. CD4 and CD8 monoclonal antibody therapy in canine renal allografts.
    Watson CJ; Cobbold SP; Davies HF; Rebello PR; Waldmann H; Calne RY; Metcalfe SM
    Transpl Int; 1994; 7 Suppl 1():S322-4. PubMed ID: 11271241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ lymphocytes play a dominant role in murine xenograft rejection.
    Pierson RN; Winn HJ; Russell PS; Auchincloss H
    Transplant Proc; 1989 Feb; 21(1 Pt 1):519. PubMed ID: 2565056
    [No Abstract]   [Full Text] [Related]  

  • 17. Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies.
    Cobbold SP; Qin S; Leong LY; Martin G; Waldmann H
    Immunol Rev; 1992 Oct; 129():165-201. PubMed ID: 1464419
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment with an anti-CD4 monoclonal antibody strongly ameliorates established rat adjuvant arthritis.
    Pelegrí C; Morante MP; Castellote C; Franch A; Castell M
    Clin Exp Immunol; 1996 Feb; 103(2):273-8. PubMed ID: 8565311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance induction with peripheral blood lymphocyte depletion using monoclonal antibodies: tip of the iceberg?
    Soin AS; Metcalfe S; Friend PJ
    Transplant Proc; 1998 Sep; 30(6):2572. PubMed ID: 9745493
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of corneal endothelial destruction in rejecting rat corneal allografts and xenografts: a role for CD4+ cells.
    Takano T; Williams KA
    Transplant Proc; 1995 Feb; 27(1):260-1. PubMed ID: 7878994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.